Gateway Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$124M Sell
135,174
-22,638
-14% -$23M 1.39% 12
2025
Q4
$170M Buy
157,812
+307
+0.2% +$294K 1.58% 12
2025
Q3
$120M Buy
157,505
+168
+0.1% +$125K 1.16% 14
2025
Q2
$123M Sell
157,337
-1,801
-1% -$1.4M 1.34% 13
2025
Q1
$131M Buy
159,138
+1,550
+1% +$1.29M 1.51% 11
2024
Q4
$122M Sell
157,588
-4,181
-3% -$3.46M 1.35% 12
2024
Q3
$143M Sell
161,769
-9,826
-6% -$8.83M 1.58% 10
2024
Q2
$155M Sell
171,595
-1,927
-1% -$1.54M 1.76% 8
2024
Q1
$135M Sell
173,522
-17,067
-9% -$12.1M 1.54% 9
2023
Q4
$111M Sell
190,589
-9,303
-5% -$5.43M 1.3% 13
2023
Q3
$107M Sell
199,892
-16,853
-8% -$8.68M 1.35% 13
2023
Q2
$102M Sell
216,745
-811
-0.4% -$340K 1.2% 15
2023
Q1
$74.7M Sell
217,556
-17,116
-7% -$5.77M 0.91% 21
2022
Q4
$85.9M Sell
234,672
-6,073
-3% -$2.15M 1.06% 15
2022
Q3
$77.8M Sell
240,745
-2,487
-1% -$788K 0.97% 19
2022
Q2
$78.9M Buy
243,232
+531
+0.2% +$159K 0.89% 23
2022
Q1
$69.5M Buy
242,701
+1,640
+0.7% +$422K 0.69% 32
2021
Q4
$66.6M Sell
241,061
-14,227
-6% -$3.61M 0.64% 39
2021
Q3
$59M Sell
255,288
-15,345
-6% -$3.79M 0.62% 40
2021
Q2
$62.1M Sell
270,633
-836
-0.3% -$168K 0.64% 36
2021
Q1
$50.7M Sell
271,469
-14,210
-5% -$2.78M 0.55% 50
2020
Q4
$48.2M Sell
285,679
-71,040
-20% -$10.6M 0.53% 51
2020
Q3
$52.8M Sell
356,719
-22,429
-6% -$3.47M 0.61% 44
2020
Q2
$62.2M Sell
379,148
-36,977
-9% -$5.68M 0.73% 36
2020
Q1
$57.7M Sell
416,125
-23,598
-5% -$3.24M 0.71% 39
2019
Q4
$57.8M Sell
439,723
-6,990
-2% -$810K 0.57% 43
2019
Q3
$50M Sell
446,713
-43,624
-9% -$4.86M 0.5% 47
2019
Q2
$54.3M Sell
490,337
-22,724
-4% -$2.68M 0.49% 47
2019
Q1
$66.6M Sell
513,061
-9,131
-2% -$1.11M 0.59% 43
2018
Q4
$60.4M Sell
522,192
-1,600
-0.3% -$179K 0.57% 45
2018
Q3
$56.2M Sell
523,792
-4,141
-0.8% -$414K 0.47% 57
2018
Q2
$45M Sell
527,933
-5,346
-1% -$439K 0.4% 73
2018
Q1
$41.3M Sell
533,279
-32,647
-6% -$2.63M 0.37% 77
2017
Q4
$47.8M Sell
565,926
-2,745
-0.5% -$234K 0.41% 71
2017
Q3
$48.6M Sell
568,671
-2,119
-0.4% -$174K 0.42% 67
2017
Q2
$47M Buy
570,790
+16,549
+3% +$1.35M 0.42% 69
2017
Q1
$46.6M Sell
554,241
-47,306
-8% -$3.79M 0.43% 66
2016
Q4
$44.2M Sell
601,547
-72,586
-11% -$5.41M 0.41% 67
2016
Q3
$54.1M Sell
674,133
-69,787
-9% -$5.59M 0.48% 59
2016
Q2
$58.6M Sell
743,920
-13,542
-2% -$1.02M 0.5% 57
2016
Q1
$54.5M Sell
757,462
-18,429
-2% -$1.39M 0.47% 58
2015
Q4
$65.4M Buy
775,891
+36,534
+5% +$3.03M 0.55% 52
2015
Q3
$61.9M Buy
739,357
+12,612
+2% +$1.06M 0.55% 52
2015
Q2
$60.7M Buy
726,745
+47,772
+7% +$3.64M 0.51% 60
2015
Q1
$49.3M Sell
678,973
-142,550
-17% -$10.1M 0.41% 73
2014
Q4
$56.7M Sell
821,523
-88,716
-10% -$5.99M 0.47% 63
2014
Q3
$59M Buy
910,239
+1,095
+0.1% +$69.3K 0.47% 61
2014
Q2
$56.5M Sell
909,144
-3,316
-0.4% -$198K 0.44% 65
2014
Q1
$53.7M Sell
912,460
-17,578
-2% -$981K 0.44% 67
2013
Q4
$47.4M Sell
930,038
-5,116
-0.5% -$256K 0.38% 74
2013
Q3
$47.1M Sell
935,154
-94,069
-9% -$4.92M 0.4% 65
2013
Q2
$50.6M Buy
+1,029,223
New +$56M 0.44% 63

Other funds holding LLY

Gateway Investment Advisers's LLY Position: Q1 2026 in Review

Gateway Investment Advisers reduced its Eli Lilly (LLY) stake by 14% in Q1 2026, selling an estimated $23M and leaving 135,174 shares worth $124M. The position accounts for 1.39% of the portfolio, ranked #12.

Gateway Investment Advisers first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $170M in Q4 2025. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gateway Investment Advisers held 135,174 shares of Eli Lilly worth $124M as of Q1 2026.
  • Gateway Investment Advisers sold 22,638 Eli Lilly shares in Q1 2026, an estimated $23M.
  • Eli Lilly made up 1.39% of Gateway Investment Advisers's portfolio in Q1 2026, its #12 holding.
  • Gateway Investment Advisers first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Gateway Investment Advisers's Eli Lilly position peaked at $170M in Q4 2025.
  • 4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gateway Investment Advisers's 13F filing for Q1 2026, filed 13 Apr 2026.